Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02766712 · ClinicalTrials.gov registry record · NA

The Physiological Effects of Pacing on Catheter Ablation Procedures to Treat Atrial Fibrillation

A NA study of Atrial Fibrillation, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
64
Enrollment target
1
Study location

NCT02766712 is a NA study of Atrial Fibrillation that has completed, run by NYU Langone Health. The registered enrollment target is 64 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02766712, a NA study of Atrial Fibrillation, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
64 participants
Enrollment target
1
Study location

Study Summary

This is a two arm randomized, paired prospective study comparing the percentage of time spent above Contact Force (CF), Force Time Integral (FTI) and other lesion parameters in the setting of pacing versus non-pacing. This study is designed to compare the percentage of time spent above CF 10 grams between paced and non-paced lesions at 15 pre-determined lesion locations.

Conditions Studied

Interventions

  • PROCEDURE Pace During 1st Half of Lesion
  • PROCEDURE Pace During 2nd Half of Lesion

Study Locations (1)

New York

  • New York University School of Medicine - New York

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2016-04
Est. Completion 2017-05-02
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT02766712

The ClinicalTrials.gov registry entry for NCT02766712 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Pace During 1st Half of Lesion is the first listed.

NCT02766712 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02766712 about?

NCT02766712 is a clinical study titled "The Physiological Effects of Pacing on Catheter Ablation Procedures to Treat Atrial Fibrillation". This is a two arm randomized, paired prospective study comparing the percentage of time spent above Contact Force (CF), Force Time Integral (FTI) and other lesion parameters in the setting of pacing versus non-pacing. This study is designed to compare the percentage of time spent above CF 10 grams b...

What is the current status of trial NCT02766712?

This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2016-04. Estimated completion is 2017-05-02.

What conditions does trial NCT02766712 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT02766712?

The interventions under investigation include: Pace During 1st Half of Lesion (PROCEDURE), Pace During 2nd Half of Lesion (PROCEDURE).

Who is sponsoring clinical trial NCT02766712?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02766712 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.